Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (MRI) study

被引:45
作者
Daumann, J
Fimm, B
Willmes, K
Thron, A
Gouzoulis-Mayfrank, E
机构
[1] Univ Technol RWTH, Fac Med, Dept Psychiat & Psychotherapy, D-52074 Aachen, Germany
[2] Univ Technol RWTH, Fac Med, Dept Neurol, Sect Neuropsychol, D-52074 Aachen, Germany
[3] Univ Technol RWTH, Fac Med, Dept Neuroradiol, D-52074 Aachen, Germany
来源
COGNITIVE BRAIN RESEARCH | 2003年 / 16卷 / 03期
关键词
MDMA; ecstasy; working memory; fMRI;
D O I
10.1016/S0926-6410(03)00075-2
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
The popular recreational drug ecstasy (3,4-methylenedioxymethamphetamine=MDMA and related congeners) is neurotoxic upon central serotonergic systems in animal studies. So far, the most convincing evidence for neurotoxicity-related functional deficits in humans derives from neurocognitive studies demonstrating dose-related long-term learning and memory problems in ecstasy users. In our study we used functional magnetic resonance imaging (fMRI) and a working memory task to investigate cerebral activation in eleven heavy, but currently abstinent MDMA users and two equally sized groups of moderate users and non-users. There were no significant group differences in working memory performance and no differences in cortical activation patterns for a conservative level of significance. However, for a more liberal statistical criterion, both user groups showed stronger activations than controls in right parietal cortex. Furthermore, heavy users had a weaker blood oxygenation level-dependent (BOLD) response than moderate users and controls in frontal and temporal areas. Our results may indicate subtle altered brain functioning associated with prior MDMA use, although alternative interpretations of these group differences must be considered. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:479 / 487
页数:9
相关论文
共 42 条
[1]  
ABRAHAM MD, 1998, LICIT ILLICIT DRUG U
[2]  
Baddeley A., 1986, WORKING MEMORY
[3]   MDMA-INDUCED NEUROTOXICITY - PARAMETERS OF DEGENERATION AND RECOVERY OF BRAIN-SEROTONIN NEURONS [J].
BATTAGLIA, G ;
YEH, SY ;
DESOUZA, EB .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1988, 29 (02) :269-274
[4]   Memory impairment in abstinent MDMA ("Ecstasy") users [J].
Bolla, KI ;
McCann, UD ;
Ricaurte, GA .
NEUROLOGY, 1998, 51 (06) :1532-1537
[5]   Imaging cognition II: An empirical review of 275 PET and fMRI studies [J].
Cabeza, R ;
Nyberg, L .
JOURNAL OF COGNITIVE NEUROSCIENCE, 2000, 12 (01) :1-47
[6]   Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): Week-end 'high' followed by mid-week low [J].
Curran, HV ;
Travill, RA .
ADDICTION, 1997, 92 (07) :821-831
[7]   Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence [J].
Dafters, RI ;
Duffy, F ;
O'Donnell, PJ ;
Bouquet, C .
PSYCHOPHARMACOLOGY, 1999, 145 (01) :82-90
[8]  
FISCHER C, 1995, J NEUROSCI, V15, P5476
[9]   No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine)users and control subjects:: A [H215O]-positron emission tomography study [J].
Gamma, A ;
Buck, A ;
Berthold, T ;
Vollenweider, FX .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (01) :66-71
[10]   Long-lasting effects of (±)3,4-methylene-dioxymethamphetamine (ecstasy) on serotonin system function in humans [J].
Gerra, G ;
Zaimovic, A ;
Ferri, M ;
Zambelli, U ;
Timpano, M ;
Neri, E ;
Marzocchi, GF ;
Delsignore, R ;
Brambilla, F .
BIOLOGICAL PSYCHIATRY, 2000, 47 (02) :127-136